Intera Atlas
Run match
Sites / Preferred Research Partners
Is this you?

Request access for Preferred Research Partners with your @preferredresearchpartners.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.

Request account

Preferred Research Partners

Unclaimed profile

Site Network · Little Rock & Fayetteville, Arkansas · ~Multiple investigator sites, 280+ trials conducted sites

WebsiteLinkedInRank for protocol
Intera lens
ICP 7Lift (cardio sample) 0.18Recruit soph 0.57
Quality Scorecard (1–100)
Overall71Recruit80Ops72Sponsor67Ther63

Performance (observed)

Historical trials
169
Completed
112
Terminated/Withdrawn
20
Completion rate
85%
Active now
34
Phase 2
45
Phase 3
102
Realized enrollment
617,372
First study year
2006
Years active
20
Match confidence
high
Enrollment velocity (inf)
30,869

Therapeutic

Areas
CNS, Psychiatry, Sleep, Gastroenterology, Metabolic, Vaccines, Pain, Devices
Specialties
CNS, Psychiatry, Sleep Medicine, Gastroenterology, Metabolic Disorders, Vaccines, Pain, Device Studies; 280+ Phase I-IV trials
Breadth (conditions)
136
Languages
English + Spanish (detected)
States
Arkansas (Little Rock, Fayetteville expansion planned)

Recruitment (web observed)

Meta Pixel
Yes
Trial Finder
Yes
Recruitment pages
Yes
Advertises recruitment
Yes
SEO
Y; extensive trial history and partnerships
Capability notes
Strong patient recruitment performance, multi-specialty

Relationships

Sponsors
AbbVie; Eli Lilly and Company; Pfizer; Allergan; Janssen Research & Development, LLC; Phathom Pharmaceuticals, Inc.
CROs
IQVIA Biotech; PPD Development, LP; Parexel; Precision For Medicine; Premier Research; Syneos Health
Partnerships
Multiple pharma/biotech partnerships
Owner / parent
Privately owned by Dr. Paul Wylie (established 2009)
Expansion
Y; new IV infusion center facility planned

Capacity & people

Investigators
—
Coordinators
—
CEO
Dr. Paul E. Wylie, MD (President)
VP Clinical Ops
Amy Kelley, BSN, RN, CCRC (Vice President)
VP Site Ops
Kelly Knight, CCRP (Research Operations Manager)
VP Recruitment
Unknown
Emails
pewyliemd@gmail.com

Tech & DCT

eSource
Yes
Builds tech
Unknown
Tech stack
Unknown specific CTMS
Recruiting visible
Y

Notes

Research-dedicated site network; 280+ Phase I-IV trials across multiple therapeutic areas; excellent multi-therapeutic diversity; strong recruitment performance; founder-led with experienced VP; dual-facility setup with research center; expanding to NWA; good Intera fit but limited to Arkansas geography [Validated: 4 active recruiting cardiometabolic trials on ClinicalTrials.gov.]

Recommendation features (sample indication)

Ind fit 0.42Liftability 0.18Overall71

FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.